11 March 2002
Effect of oral supplementation of free amino acids in type 2 diabetic patients: a pilot clinical trial.
Sivaramakrishna Ramakrishnan, Tharigopala Arokiasamy, Baluswamy Sukumar, Soundarajan Lakshmi, Konerirajapuram Natarajan Sulochana, Ranganathan PunithamMed Sci Monit 2002; 8(3): CR131-137 :: ID: 420914
Abstract
BACKGROUND: Oral amino acid intake reduces plasma glucose in Streptozotocin-induceddiabetic rats. This study examined the effect of oral amino acid supplementation in patients with type2 diabetes mellitus (DM). MATERIAL/METHODS: A double blind pilot clinical trial was conducted for a periodof 2 months on 77 subjects with type 2 DM. Subjects of both sexes, ages 30-60, were included in the trial.All were receiving oral antidiabetic tablets. They were divided into groups on the basis of oral supplementation:(A) lysine, (B) essential amino acids, (C) amino acids and vitamins (fat and water-soluble), and (D)calcium phosphate (control). The subjects were periodically examined for fasting and post-prandial plasmaglucose, fasting and post-prandial immunoreactive insulin, plasma amino acids, glycosylated haemoglobin(HbA1c), proteins and albumin in serum, urea and creatinine in plasma and sugar, and proteins and ketonesin urine. RESULTS: The results revealed a significant decrease in PP plasma glucose (P<0.05) in group B when compared to groups C and D after 45 days. Plasma Arginine was increased in group C from 3.84 to 9.24 mg/dl. There were no statistically significant changes seen in other parameters between groups and visits.
Conclusions: Oral supplementation with amino acids for patients with type 2 DM appears to decrease PP plasma glucose without any change in plasma insulin levels, perhaps due to improved insulin sensitivity. However, the long term effects of amino acids need further study.
Keywords: Administration, Oral, Amino Acids, Blood Glucose, Body Mass Index, Diabetes Mellitus, Type 2, Double-Blind Method, Insulin, Lysine, Pilot Projects
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
17 Mar 2024 : Clinical Research
Protective Role of TRPC3 Gene Polymorphism (rs10518289) in Obstructive Sleep Apnea Hypopnea Syndrome Among ...Med Sci Monit In Press; DOI: 10.12659/MSM.942667
27 Mar 2024 : Clinical Research
Impact of Patient Education Formats on Treatment Adherence and Denture Hygiene in Edentulous Patients: A Co...Med Sci Monit In Press; DOI: 10.12659/MSM.944175
27 Mar 2024 : Clinical Research
Incidence, Risk Factors, and Outcomes of Left Atrial Enlargement in Patients Requiring Right Ventricular Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.944114
15 May 2024 : Database Analysis
MRTO4 Enhances Glycolysis to Facilitate HCC Progression by Inhibiting ALDOBMed Sci Monit In Press; DOI: 10.12659/MSM.944685
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952